Yield10 Bioscience, Inc. Common Stock
YTEN
YTEN was delisted on the 15th of May, 2024.
10 hedge funds and large institutions have $925K invested in Yield10 Bioscience, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 10 → 10 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
12% less capital invested
Capital invested by funds: $1.05M → $925K (-$128K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$41.1K |
| 2 |
GC
GMT Capital
Atlanta,
Georgia
|
+$33.5K |
| 3 |
VF
Virtu Financial
New York
|
+$6.69K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.78K |
| 5 |
HDIM
Hanson & Doremus Investment Management
Burlington,
Vermont
|
+$2.87K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$49K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$12.4K |
| 3 |
APA
American Portfolios Advisors
Holbrook,
New York
|
-$18 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $463K | +$41.1K | +43 | +9% |
|
|
BC
2
Birchview Capital
Burlington,
Vermont
| $120K | – | – | – |
|
|
CC
3
Cannell & Co
New York
| $112K | – | – | – |
|
4
Vanguard Group
Malvern,
Pennsylvania
| $98K | – | – | – |
|
|
5
Geode Capital Management
Boston,
Massachusetts
| $56K | +$4.78K | +5 | +9% |
|
|
GC
6
GMT Capital
Atlanta,
Georgia
| $33K | +$33.5K | +35 | New |
|
|
VF
7
Virtu Financial
New York
| $18K | +$6.69K | +7 | +58% |
|
8
BlackRock
New York
| $14K | – | – | – |
|
|
HDIM
9
Hanson & Doremus Investment Management
Burlington,
Vermont
| $9K | +$2.87K | +3 | +43% |
|
10
Morgan Stanley
New York
| $2K | +$2.87K | +3 | New |
|
|
11
Citadel Advisors
Miami,
Florida
| – | -$49K | -45 | Closed |
|
|
12
UBS Group
Zurich,
Switzerland
| – | -$12.4K | -13 | Closed |
|
|
APA
13
American Portfolios Advisors
Holbrook,
New York
| – | -$18 | – | – |
|
YTEN Hedge Fund Activity: Q2 2019 in Review
10 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q2 2019, worth a combined $925K — down 12% from $1.05M a quarter earlier.
Fund positioning in YTEN was balanced in Q2 2019: 2 funds opened new positions, 2 closed out, 4 added to existing stakes and 0 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $41.1K. The largest seller was Citadel Advisors, exiting entirely with an estimated $49K sold.
- 10 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q2 2019, unchanged from Q1 2019.
- Funds reported $925K of Yield10 Bioscience, Inc. Common Stock stock for Q2 2019, down 12% quarter-over-quarter.
- 2 funds opened new Yield10 Bioscience, Inc. Common Stock positions in Q2 2019 and 2 closed out, a net change of 0 holders.
- The largest Yield10 Bioscience, Inc. Common Stock buyer in Q2 2019 was Renaissance Technologies, an estimated $41.1K added.
- The largest Yield10 Bioscience, Inc. Common Stock seller in Q2 2019 was Citadel Advisors, an estimated $49K sold.
Based on aggregated 13F filings for Q2 2019.